Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033

NCT00376285 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: CP-742,033
DRUG: Fenofibrate

Sponsor

Pfizer